Invention Grant
- Patent Title: Methods and compositions involving miRNA and miRNA inhibitor molecules
-
Application No.: US11837487Application Date: 2007-08-10
-
Publication No.: US08563708B2Publication Date: 2013-10-22
- Inventor: David Brown , Lance Ford , Angie Cheng , Rich Jarvis , Mike Byrom , Dmitriy Ovcharenko , Eric Devroe , Kevin Kelnar
- Applicant: David Brown , Lance Ford , Angie Cheng , Rich Jarvis , Mike Byrom , Dmitriy Ovcharenko , Eric Devroe , Kevin Kelnar
- Applicant Address: US TX Austin
- Assignee: Asuragen, Inc.
- Current Assignee: Asuragen, Inc.
- Current Assignee Address: US TX Austin
- Agency: Nutter McClennen & Fish LLP
- Agent Konstantin Linnik
- Main IPC: C07H21/04
- IPC: C07H21/04
Abstract:
The present invention concerns methods and compositions for introducing miRNA activity or function into cells using synthetic nucleic acid molecules. Moreover, the present invention concerns methods and compositions for identifying miRNAs with specific cellular functions that are relevant to therapeutic, diagnostic, and prognostic applications wherein synthetic miRNAs and/or miRNA inhibitors are used in library screening assays.
Public/Granted literature
- US20080176766A1 METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES Public/Granted day:2008-07-24
Information query
